In a comprehensive study of 45 nevi and 70 melanomas with molecular correlation, He et al. [46] demonstrated that MTAP loss is a highly specific surrogate marker for CDKN2A homozygous deletion, though with limited sensitivity. This evidence concerns the gene CDKN2A and melanoma.